Mahindra Manulife Consumption Fund vs Mirae Asset Healthcare Fund
Thematic Fund · Direct Plan – Growth · Compared on official AMFI NAV data · NAVs as of 28-Jul-2026
| Metric | Mahindra Manulife Consumption Fund | Mirae Asset Healthcare Fund |
|---|---|---|
| Latest NAV | ₹24.91 | ₹50.79 |
| 1-Year Return | -0.61% | +18.16% |
| 3-Year Return (CAGR) | +11.54% | +26.53% |
| 5-Year Return (CAGR) | N/A | N/A |
| Volatility (1Y, annualised) | 13.6% | 13.7% |
| Max Drawdown | −22.7% | −15.9% |
| Fund House | Mahindra Manulife Mutual Fund | Mirae Asset Mutual Fund |
Growth of ₹10,000
If you had invested ₹10,000 in each fund
Embed this chart on your site (free)
Copy this code into your website or blog. It stays up to date automatically.
<iframe src="https://moneydock.in/embed/fund-compare/mahindra-manulife-consumption-fund-vs-mirae-asset-healthcare-fund" width="100%" height="520" style="border:1px solid #e5e7eb;border-radius:12px;max-width:760px" title="Mahindra Manulife Consumption Fund vs Mirae Asset Healthcare Fund by MoneyDock" loading="lazy"></iframe> <p style="font-size:12px">Powered by <a href="https://moneydock.in" target="_blank" rel="noopener">MoneyDock</a></p>
See the embed documentation for all widgets, sizing options and usage terms.
Mahindra Manulife Consumption Fund vs Mirae Asset Healthcare Fund: which is better?
Mahindra Manulife Consumption Fund and Mirae Asset Healthcare Fund are both thematic fund mutual funds (direct plan, growth option). This comparison uses each fund's official AMFI NAV history — the same daily data the fund houses publish — to compare returns, volatility and drawdowns side by side.
On 3-year returns (annualised), Mirae Asset Healthcare Fund leads with +26.53% against +11.54% — a gap of about 14.99 percentage points per year over that period.
Mahindra Manulife Consumption Fund has been the steadier fund over the past year, with annualised volatility of 13.6% versus 13.7%. Looking at worst falls, Mahindra Manulife Consumption Fund's deepest drawdown in the stored history is −22.7% against −15.9% for Mirae Asset Healthcare Fund.
Which fund suits you depends on your horizon and appetite for swings: the higher-return fund is only the better pick if you can hold through its rougher months. Use the ₹10,000 growth chart above to see how each fund actually behaved through market cycles, and consider consulting a SEBI-registered adviser before investing. This comparison is informational, not investment advice.
Key takeaways
- Mirae Asset Healthcare Fund has delivered higher 3-year returns (+26.53% vs +11.54%).
- Mahindra Manulife Consumption Fund has shown lower volatility over the trailing year.
- Mirae Asset Healthcare Fund has had the shallower maximum drawdown (−15.9%).
Frequently Asked Questions
Which fund has given higher returns — Mahindra Manulife Consumption Fund or Mirae Asset Healthcare Fund?
Over the past 3 year period, Mirae Asset Healthcare Fund has delivered higher returns: +26.53% versus +11.54% annualised. Past performance does not guarantee future results.
Which fund is less risky — Mahindra Manulife Consumption Fund or Mirae Asset Healthcare Fund?
Based on the trailing year, Mahindra Manulife Consumption Fund has shown lower day-to-day volatility (Mahindra Manulife Consumption Fund: 13.6%, Mirae Asset Healthcare Fund: 13.7% annualised). Volatility and drawdowns describe past behaviour, not future safety — both funds carry the market risk of their category.
Can I invest in both Mahindra Manulife Consumption Fund and Mirae Asset Healthcare Fund?
Yes — many investors split a SIP across two funds. If both funds are from the same category, remember they will hold overlapping stocks, so diversification benefits may be smaller than they appear. Check each scheme's portfolio before doubling up within one category.
More Thematic Fund comparisons
Returns, volatility and drawdowns are computed from official AMFI NAV history for direct-growth plans and may differ slightly from fund-house factsheets due to date conventions. Mutual fund investments are subject to market risks. This comparison is for informational purposes only — not investment advice.